v3.26.1
Net Loss Per Share Attributable to Common Stockholders - Additional Information (Details) - $ / shares
6 Months Ended
Apr. 13, 2026
Jun. 30, 2026
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
Issuance of common stock upon exercise of pre-funded warrants, Shares 799,987  
Pre Funded Warrant [Member]    
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
Warrants to purchase common stock   800,000
Purchase price   $ 9.9999
Warrants outstanding   0
Warrants exercised date   Apr. 13, 2026